Paola Imbrici

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Correction: Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies.

Correction: Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies.

Journal: Frontiers in pharmacology

Published: July 16, 2026

Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12-month real-world study in refractory and ultra-refractory focal epilepsy.

Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12-month real-world study in refractory and ultra-refractory focal epilepsy.

Journal: Epilepsia open

Published: March 30, 2026

Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies.

Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies.

Journal: Frontiers in pharmacology

Published: March 13, 2026

State-of-the-Art Research and New Pharmacological Perspectives on Renal Involvement in Duchenne Muscular Dystrophy: A Narrative Review.

State-of-the-Art Research and New Pharmacological Perspectives on Renal Involvement in Duchenne Muscular Dystrophy: A Narrative Review.

Journal: Biomedicines

Published: December 20, 2025

Selenoprotein N and SEPN1-Related Myopathies: Mechanisms, Models, and Therapeutic Perspectives.

Selenoprotein N and SEPN1-Related Myopathies: Mechanisms, Models, and Therapeutic Perspectives.

Journal: Biomolecules

Published: December 19, 2025

Expanding the phenotypic spectrum of CACNA1A-related developmental and epileptic encephalopathy in adults.

Expanding the phenotypic spectrum of CACNA1A-related developmental and epileptic encephalopathy in adults.

Journal: Epileptic disorders : international epilepsy journal with videotape

Published: November 21, 2025

From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders.

From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders.

Journal: International journal of molecular sciences

Published: November 07, 2025

Restoring brain wiring, mobility, sleep, and lifespan with a novel repurposed modulator of voltage-gated K+ channels: an emerging perspective for channelopathies.

Restoring brain wiring, mobility, sleep, and lifespan with a novel repurposed modulator of voltage-gated K+ channels: an emerging perspective for channelopathies.

Journal: Journal of translational medicine

Published: October 16, 2025

Restoring brain wiring, mobility, sleep, and lifespan with a novel repurposed modulator of voltage-gated K+ channels: an emerging perspective for channelopathies.

Restoring brain wiring, mobility, sleep, and lifespan with a novel repurposed modulator of voltage-gated K+ channels: an emerging perspective for channelopathies.

Journal: Journal of translational medicine

Published: October 16, 2025

Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses.

Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses.

Journal: Frontiers in pharmacology

Published: October 07, 2025

Towards development of Nav1.7 channel modulators for pain treatment: A comparison of mexiletine effect in two cell models by automated patch clamp.

Towards development of Nav1.7 channel modulators for pain treatment: A comparison of mexiletine effect in two cell models by automated patch clamp.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 30, 2025

Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice.

Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice.

Journal: Frontiers in pharmacology

Published: February 27, 2025

Showing 1-12 of 88

Last Updated: 09/26/2026